Skip to main content

Table 2 Plausibility and relevance of published sampling schemes using data from three empirical surveys

From: Improving valuation sampling of EQ-5D health states

 

Valuation study

 

UK / Spain / US

Denmark

Germany

Japan / Netherlands

States valued#

43

47

36

18

States valued but not present in observational data set /implausible

HSE96

12 (28%)

10 (23%)

9 (21%)

5 (12%)

CODE-2

9 (21%)

7 (16%)

5 (12%)

4 (9%)

HoDAR

3 (7%)

2 (5%)

1 (2%)

2 (5%)

Coverage of total responses in observational data set /relevance

HSE96

82%

88%

82%

74%

CODE-2

63%

78%

68%

49%

HoDAR

58%

75%

57%

44%

  1. # including ‘no problems’ state (11111).
  2. HSE96 Health Survey for England 1996 [11].
  3. CODE-2 Cost of Diabetes in Europe: Type-2 [12].
  4. HoDAR Health Outcomes Data Repository [10].